Thermo Fisher Scientific Oncomine Clinical Research Grant Program

Overview

The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects, on molecular testing in oncology and reproductive health, with the goal to increase high quality molecular profiling for patients and to improve clinical outcomes in the future.

Proposal reviews are conducted by independent and internationally recognized experts together with Thermo Fisher Scientific medical and scientific leadership. Funding is considered based on scientific merit and alignment with strategic areas of focus.

The application process is managed by the Oncomine Clinical Research Grant Office part of the Medical Affairs team of the Clinical Sequencing Division at Thermo Fisher Scientific. For detailed information about how to apply, including documentation requirements, review process, and decision notification, refer to the document Guidelines for Applicants.

Grant Details

Grant applications should be submitted electronically (English only) using the specific Proposal Form.  Proposals should outline the planned activities to be performed within a maximum of 12 months. A budget is required for every grant request and should detail the proposed use of requested funds. The maximum budget request for each project is set at $200,000.

GRANT SUBMISSION DATES:

Submissions are open from February 22 to March 29, 2021.

TOPICS OF CALL:

Liquid Biopsy in Oncology

Download Proposal Form

Submit Grant Proposal

Grant Selection Process

• Submission:  Submission is done by sending the Proposal Form to the following email address: [email protected] or using the online grant management portal.
• Evaluation:  Submission will be confirmed by the Grant Office via email. Decisions will be communicated 8 weeks after the closing date of the call.
• Execution:  Upon contract signature, the requested financial support will be granted. The Grant Office team will continue to support the development of the awarded project. A final report is due to the Grant Office team within the agreed time frame.

Contact

For any questions about the Oncomine Clinical Research Grant Program, please email [email protected].

View Notification